Grant funding to support the development of the ACP Practice Advisor® has been received from the following organizations:
Foundations and Public Funding
|
Centers for Disease Control and Prevention
www.cdc.gov
Editorial direction and production of the "Immunize Adults" module were provided by a cooperative agreement with the Centers for Disease Control and Prevention.
|
 |
United Health Foundation
www.unitedhealthfoundation.org
United Health Foundation provided funding to support early development of the original Practice Advisor platform.
|
|
American Board of Internal Medicine Foundation
www.abimfoundation.org
The American Board of Internal Medicine Foundation provided funding to support the Facilitate Transitions II module.
|
|
Arthritis Foundation
www.arthritis.org
The Arthritis Foundation provided funding to support the Rheumatoid Arthritis, Gout, and Osteoarthritis modules (coming Fall 2013).
In addition, Arthritis Foundation funding supported development of the Maintenance of Certification features.
|
 |
National Institute on Drug Abuse (NIDA)
www.drugabuse.gov
NIDA provided funding and expertise for the "Substance Use Disorder" and "Motivational Interviewing" modules. Their funding also supported the creation of the MOC module "Substance Use Disorder".
|
Industry
The following Practice Advisor sections were supported in part by grants from the following organizations:
| |
Pfizer, Inc.
www.pfizer.com
Early development of the original Practice Advisor platform and development of the section called “Practice-to-Practice Pearls.”
Development of a 2010 series of webinars included as enduring resources on this site.
Development of the module “Managing Patients' Medications.”
Development of the module "Engage Patients."
Development of video "Medication Adherence: We Didn't Ask & They Didn't Tell."
Development of video "Medication Adherence: Challenges and Solutions."
|
| |
NovoNordisk
www.novonordisk-us.com
Development of the clinical module “Manage Diabetes Mellitus.”
|
|
Endo Pharmaceuticals Inc.
www.endo.com
Development of two clinical modules: “Chronic Pain Management” and "Opioid Risk Management."
|
|
Bristol-Myers Squibb
www.bms.com
Development of the clinical module “Depression Screening & Care.”
|
|
Lilly USA, LLC
www.lilly.com
Development of the Patient-Centered Specialty Program modules.
|
|
AstraZeneca
www.astrazeneca.com
Development of the clinical module “Depression Screening & Care.”
|
| |
CardioDX
www.cardiodx.com
Development of the clinical module "Assessing Cardiovascular Risk"
|